ライフサイエンスコーパス: photosensitizing

1 The in vivo photosensitizing ability of melanin is unknown.

2 The triplet photosensitizing ability of preoxidized DOM was determin

3 lasmids, is examined as a potential cellular photosensitizing agent and offers unique opportunities a

4 ew treatment modality, uses a combination of photosensitizing agent and visible light for the therapy

5 ophobic PSs to a cationic peptide produces a photosensitizing agent effective against Gram-negative b

6 This paper describes the accumulation of the photosensitizing agent protoporphyrin IX in areas of pla

7 therapy (PDT), cells are impregnated with a photosensitizing agent that is activated by light irradi

8 (PDT), using aluminum phthalocyanine as the photosensitizing agent.

9 ommended for adequate penetration of topical photosensitizing agents and subsequent protoporphyrin IX

10 sis on biological evaluation of FDA approved photosensitizing agents as well as newly designed nanoph

11 mpounds of vegetable origin that are used as photosensitizing agents in the treatment of various skin

12 enhancing intracellular accumulation of the photosensitizing agents used in this study, we propose t

13 braries of potential chemical and biological photosensitizing agents.

14 oximately 30 nm), entrapping water-insoluble photosensitizing anticancer drug 2-devinyl-2-(1-hexyloxy

15 ith BCC, and especially early-onset BCC, and photosensitizing antimicrobials.

16 ew modality that utilizes a combination of a photosensitizing chemical and visible light for the mana

17 er treatment that employs a combination of a photosensitizing chemical and visible light, induces apo

18 is a bimodal therapy using a porphyrin based photosensitizing chemical and visible light.

19 us demonstrating selective destruction of HS photosensitizing chromophores.

20 kin cancer, involves the administration of a photosensitizing compound followed by illumination of th

21 ilamentous Cercospora fungi are resistant to photosensitizing compounds that generate singlet oxygen.

22 rapy (PDT) depends upon the delivery of both photosensitizing drug and oxygen.

23 Irradiation of the photosensitizing drug entrapped in nanoparticles with li

24 Photochemotherapy-in which a photosensitizing drug is combined with ultraviolet or vi

25 (a) the localization in the target site of a photosensitizing drug; and (b) the activation of the pho

26 ar degeneration, using laser activation of a photosensitizing dye to achieve closure of choroidal neo

27 amic therapy is the combination of non-toxic photosensitizing dyes with harmless visible light that t

28 ores the importance of these products in the photosensitizing effect of BrdU.

29 yrimidines in duplex DNA may account for the photosensitizing effects of these nucleosides.

30 s (R- and S-isomers) showed similar in vitro photosensitizing efficacy and limited skin phototoxicity

31 -4)-Glc) produced a considerable increase in photosensitizing efficacy in vitro.

32 relation between 17 displacement ability and photosensitizing efficacy of photosensitizers was observ

33 The photosensitizing efficacy of the monomers and the relate

34 The preliminary in vivo photosensitizing efficacy of this stable bacteriopurpuri

35 tion between the binding constant values and photosensitizing efficacy was observed.

36 stituted-imide ring system produced enhanced photosensitizing efficacy with limited skin phototoxicit

37 ectroscopic properties, preliminary in vitro photosensitizing efficacy, and tumor selectivity were de

38 esis, photophysical characteristics, in vivo photosensitizing efficacy, human serum albumin (HSA) bin

39 osition-132) of the molecule showed enhanced photosensitizing efficacy.

40 fluoromethyl)benzylamine, produced promising photosensitizing efficacy.

41 d lactose) produced a 100% decrease in their photosensitizing efficacy.

42 conjugate did not show any inhibition in its photosensitizing efficacy.

43 arbon-carbon linked dimers produced enhanced photosensitizing efficacy.

44 /cm2, all benzochlorins produced significant photosensitizing efficacy.

45 nding site (albumin site II) and the in vivo photosensitizing efficacy.

46 to investigate possible associations between photosensitizing medication use and NMSC.

47 examine the association between a history of photosensitizing medication use and non-melanoma skin ca

48 ge) (OR=1.5, 95% CI=1.1-2.1) associated with photosensitizing medication use.

49 In conclusion, certain commonly prescribed photosensitizing medications may enhance the risk of dev

50 the concomitant loss of chromophores (i.e., photosensitizing moieties).

51 moieties had larger effects than the loss of photosensitizing moieties.

52 clined, mainly reflecting the destruction of photosensitizing moieties.

53 encoded proteins that form or bind a native photosensitizing molecule, resulting in a constitutively

54 isting of plasmonic silver nanoparticles and photosensitizing molecules, where strong resonance coupl

55 gates as an energy up-converting donor and a photosensitizing PDT drug as an acceptor.

56 euronal nAChRs and open a general pathway to photosensitizing pentameric ligand-gated ion channels.

57 Recently, photocatalytic systems based on photosensitizing perylene monomimide (PMI) chromophore a

58 Their photosensitizing potential for photodynamic therapy was

59 Although the photosensitizing properties of estrogens have been recog

60 t further motivates to explore the potential photosensitizing properties of small alkyl-substituted i

61 The photochemistry and photosensitizing properties of the kinds of biogenically

62 urther explores the correlations between the photosensitizing properties of WWOM and optical characte

63 ts of DOM preoxidation on the inhibiting and photosensitizing properties were assessed by phototransf

64 ntaining BODIPY chromophores having tuneable photosensitizing properties.

65 Cell-specific genetically encoded photosensitizing proteins, such as KillerRed, permit spa

66 Development of a photosensitizing system that can reversibly control the

67 eme is selective toward molecules capable of photosensitizing the formation of singlet molecular oxyg